Clinical trials sponsored by University of Oklahoma

Phase breakdown

Conditions studied

Recruiting trials led by University of Oklahoma

• Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0
  NCT06488781 · Phase: Phase 2 · Ages: 15 Years to 45 Years · Sex: Female · 1 location
• Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)
  NCT06960798 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: Male · 1 location
• Connect2Care: Prostate Cancer Education and Screenings for African American Men
  NCT07055165 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 69 Years · Sex: Male · 1 location
• Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)
  NCT05174052 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma
  NCT07254910 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 75 Years · Sex: All (male and female) · 1 location
• IN Midazolam vs IN Dexmedetomidine vs IN Ketamine During Minimal Procedures in Pediatric ED
  NCT05934669 · Phase: Phase 4 · Ages: 1 Year to 5 Years · Sex: All (male and female) · 1 location
• Impact of Semaglutide on Tobacco Use and Related Health Behaviors
  NCT06986993 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Low Level Tragus Stimulation in Acute Decompensated Heart Failure
  NCT02898181 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer
  NCT07014618 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy
  NCT05921253 · Phase: Early Phase 1 · Ages: 18 Years to 99 Years · Sex: All (male and female) · 2 locations
• Neuromodulation of Inflammation and Endothelial Function
  NCT05230732 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Relugolix + Enzalutamide Study in High-Risk Prostate Cancer
  NCT06130995 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 1 location
• Remote Physical Activity Programming to Improve Outcomes in Cancer Survivors With and Without Type 2 Diabetes
  NCT06725953 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Spirometric Response to Bronchial Thermoplasty in Patients With Severe Asthma
  NCT02241265 · Phase: Not specified · Ages: 18 Years to 99 Years · Sex: All (male and female) · 1 location
• Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation
  NCT06137040 · Phase: Early Phase 1 · Ages: 5 Years to 17 Years · Sex: All (male and female) · 1 location
• Using Light Therapy for Mild Cognitive Impairment
  NCT07651787 · Phase: Not applicable (e.g. observational or device study) · Ages: 55 Years to 95 Years · Sex: All (male and female) · 1 location
• ctDNA Assay in Patients With Resectable Pancreatic Cancer
  NCT05052671 · Phase: Not specified · Ages: 18 Years to 99 Years · Sex: All (male and female) · 2 locations

Common questions

How many trials is University of Oklahoma recruiting for?

University of Oklahoma is the lead sponsor of 17 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.